Idenix Pharmaceuticals (IDIX)

[DewDiligence]

69% of Baraclude sales in 3Q07 were outside the US. This is consistent with statements made by IDIX management that the Tyzeka uptake has been faster outside the US. However, Tyzeka has already been launched in only two of the major European countries (UK and Germany), so it is still early days.